CellaVision AB
STO:CEVI
Operating Margin
CellaVision AB
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| SE |
|
CellaVision AB
STO:CEVI
|
3.8B SEK |
25%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
226B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
183.4B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
151.7B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
141.7B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.9B USD |
19%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52.4B EUR |
13%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.9B USD |
14%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.9B USD |
28%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
261.7B CNY |
36%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35.7B USD |
29%
|
CellaVision AB
Glance View
CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on CellaVision AB's most recent financial statements, the company has Operating Margin of 24.6%.
You don't have any saved screeners yet